Goldenberg BT, Samuelsen BT, Spratt JD, et al. - The present study was intended to assess the complication rates and implant survivorship of reverse total shoulder arthroplasty (RTSA) in younger patients. Researchers conducted a systematic review of the literature regarding the existing evidence on RTSA in patients younger than 65 years applying the CENTRAL (Cochrane Central Register of Controlled Trials), PubMed, and Embase databases on June 9, 2019. They distinguished articles published between 1995 and 2019 with combinations of the following keywords: “reverse shoulder arthroplasty” and “65,” “60,” and/or “55.” They further noted complications, reoperations, and revisions. Range of motion and clinical outcomes, along with postoperative radiographic results, were recorded. They collected data from 7 studies with a total of 286 shoulders for quantitative analysis. The data showed that RTSA was found to be safe and effective in patients younger than 65 years. The study found similar complication, reoperation, and revision rates to those seen in older patient cohorts, without an increase in revisions owing to aseptic loosening. It was noted that clinical outcome scores exhibited significant and lasting improvements.